Location: Home
  • search
  • go
  • Relate News
  • 3/27/2019WuXi STA's New Drug Product Manufacturing Facility Passes First Europe...
  • 3/27/2019Internal Reference for the National Adjuvant Drug List Said to Contain...
  • 3/27/2019RegeneRx and Lee's Pharm to Accelerate RGN-259 Development in China
  • 3/27/2019Oramed Granted Chinese IND Approval for Its Oral Insulin Capsules
  • 3/26/2019NMPA Suspends API Imports from Two Indian Pharma Companies
  • 3/26/2019China Pledges Accelerated Review and Approval of New and Orphan Drugs ...
  • 3/26/2019AstraZeneca Chairman Optimistic about Chinese Healthcare Market
  • 3/26/2019Medtronic Launches Medtech Innovation Accelerator in Shanghai
  • 3/26/2019Korean Biosimilar Firm Celltrion to Launch Chinese JV in H1/2019
  • 3/26/2019Merck KGaA Remains Upbeat About China’s Pharma Market
  • 3/26/2019HitGen and Almirall Enter DNA-Encoded Library Based Innovative Drug Di...
  • 3/26/2019RDPAC Releases New Report - "Faces of Innovation: Meeting the Challeng...
  • 3/25/2019State Council Issues Policy to Implement Merger of UEBMI and Maternity...
  • 3/22/2019Recent Executive Movements
  • 3/21/2019WuXi STA forms Strategic Partnership with Beta Pharma
  • 3/21/2019Chinese Pharmacopoeia Commission Opens to the Public for Development a...
  • 3/21/2019Review and Outlook of China's Foreign Trade of Medicines and Health Pr...
  • 3/21/2019Why China's New Legal Framework Will Be A Magnet for Global Pharmaceut...
  • 3/21/2019Merck To Collaborate with GenScript to Accelerate Cell and Gene Therap...
  • 3/20/2019China Needs 30 Times Its Outsourcing Capacity to Meet Biologics Demand...
  • 3/20/2019MorphoSys and I-Mab Announce Initiation of Pivotal Phase 2 Study of Mu...
  • 3/19/2019MilliporeSigma to Collaborate with GenScript to Accelerate Cell and Ge...
  • 3/19/2019ImmunoBiology and CNBG Enter Licensing Pact to Co-Develop Vaccine for ...
  • 3/19/2019Korean Pharma Il-yang and Hanmi Report Robust Sales Growth in China
  • 3/19/2019Merck KGaA Aims to Double China Sales by 2025
  • 3/17/2019Xynomic Pharma Gains Phase III Trial Approval for Novel RCC Drug Combo...
  • 3/17/20195 Key Elements of Chinese Biopharma's "Cambrian Explosion"
  • 3/15/2019NHSA Releases 2018 Healthcare Security Sector Development Statistical ...
  • 3/15/2019Recent Executive Moves
  • 3/15/2019China Approves New Law against Forced Tech Transfers
  • Page:147/360 Total number of articles:10791: [First][<<] [145] [146] [147] [148] [149] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group